Compare Edgewise Therapeutics Inc. Common Stock (EWTX) vs Wells Fargo & Co (WFC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Edgewise Therapeutics Inc. Common Stock vs Wells Fargo & Co — how do they compare? Edgewise Therapeutics Inc. Common Stock trades at $37.11 (market cap $3.94B), while Wells Fargo & Co trades at $80.9 (market cap $242.35B). The key difference: Wells Fargo & Co is far larger — about 61.5× Edgewise Therapeutics Inc. Common Stock's market cap, and Wells Fargo & Co pays a 2.48% dividend while Edgewise Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Edgewise Therapeutics Inc. Common Stock for 0 Days and Wells Fargo & Co for 88 Days on average.
| EWTX | WFC | |
|---|---|---|
Market Cap | $3.94B | $242.35B |
Volume | 810,104 | 25,561,701 |
Sector | Health | Financials |
52-Week High | $48.35 | $96.40 |
52-Week Low | $14.89 | $73.42 |
Typical Hold Time | 0 Days | 88 Days |
Enterprise Value | $3.48B | $424.64B |
Dividend Yield | — | 2.48% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Wells Fargo (WFC) trades at $80.74, down 3.07% today, with a bullish technical signal but mixed indicators. The stock shows strong profitability with a 25.97% net income margin and trades at a P/E of 11.74, below the industry average. Recent earnings beat expectations in two of the last three quarters, and a credit rating upgrade to 'A-' by S&P on October 1, 2026, reflects improved risk management.
The outlook is positive with a consensus price target of $98, implying 21% upside, supported by stable Fed stress tests and potential net interest income growth from rate hikes. Risks include volatile cash flows, with operating cash flow negative in 2025, and sensitivity to economic cycles. Institutional sentiment is balanced with 47% buy and hold ratings each.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Edgewise Therapeutics Inc. Common Stock
Edgewise Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops small-molecule therapies based on its research in muscle physiology, with a pipeline focused on cardiovascular and cardiometabolic conditions such as hypertrophic cardiomyopathy and heart failure.
Read more on EWTX →About Wells Fargo & Co
Wells Fargo is one of the largest banks in the United States, with approximately $1.9 trillion in balance sheet assets. The company is split into four primary segments: consumer banking, commercial banking, corporate and investment banking, and wealth and investment management. It is almost entirely focused on the U.S.
Read more on WFC →
